What Is 6c Peptide (Unmodified P21)?
6c Peptide (Unmodified P21) is a synthetic tetrapeptide corresponding to Ac-DGGL-NH₂, the minimal active sequence identified within a larger CNTF-derived research peptide known as Peptide 6 (Ac-VGDGGLFEKKL-NH₂). It is used as an experimental compound to investigate how this short DGGL motif relates to neurotrophic signaling observed in CNTF research.
The compound's compact, unmodified structure allows researchers to examine the core sequence responsible for reported neurotrophic activity, separate from the adamantane-based modification found in the related compound P021. Because P021 was engineered by adding an adamantylated glycine residue to this same DGGL core to improve blood-brain-barrier permeability and metabolic stability, 6c Peptide serves as an important reference point in structure-activity research comparing modified and unmodified forms of the sequence.
Current understanding of the unmodified 6c sequence is derived primarily from broader CNTF-derived peptide research, including investigations of Peptide 6 and P021 in cellular and rodent models. Within this context, researchers use the unmodified sequence as a comparative reference when studying neurotrophic signaling, BDNF-associated pathways, neuronal progenitor activity, and synaptic plasticity.
Available scientific evidence is primarily based on laboratory and preclinical research. These findings are intended to support understanding of molecular mechanisms and should not be interpreted as evidence of medical applications or therapeutic use.
Bluum Peptides supplies 6c Peptide as a research-grade tetrapeptide supported by quality documentation, including Certificates of Analysis (COAs) and third-party analytical verification where applicable. 6c Peptide is supplied strictly for laboratory research use and is not intended for human or veterinary application.
6c Peptide Mechanism of Action (Research Context)
6c Peptide is studied for its relationship to ciliary neurotrophic factor (CNTF) signaling pathways. Researchers have proposed that the DGGL core sequence may contribute to signaling mechanisms observed in related CNTF-derived peptides. Much of the available evidence comes from studies of Peptide 6 and P021 rather than isolated investigations of 6c itself.
Structural Characteristics
6c Peptide is a short, acetylated and amidated tetrapeptide (Ac-DGGL-NH₂) lacking any bulky terminal modification. Its compact structure makes it a useful reference compound for researchers studying how terminal chemical modifications, such as the adamantane group added in P021, alter permeability, stability, and receptor interaction relative to the unmodified parent sequence.
LIF/BDNF Signaling Interaction
The primary research focus of 6c Peptide is its proposed role in partially inhibiting LIF signaling through the STAT3 pathway, a mechanism associated with increased dentate gyrus neurogenesis in related CNTF-derived peptide research. Researchers use this compound to investigate how this minimal sequence contributes to BDNF transcriptional activation independent of larger modifications.
Neuroplasticity and Progenitor Cell Signaling
Research involving related CNTF-derived peptides has examined neuronal progenitor activity and synaptic plasticity in experimental models. The unmodified 6c sequence is commonly discussed as a reference compound when evaluating the contribution of the DGGL motif to these observed molecular effects.
These studies help characterize molecular mechanisms and structure-function relationships rather than demonstrate therapeutic effects.
Research Significance
6c Peptide serves as a valuable research tool for investigating the minimal active sequence underlying CNTF-mimetic neurotrophic peptides, and for comparative structure-activity research against adamantylated analogs such as P021. Ongoing studies continue to explore its role in understanding neurogenesis, BDNF regulation, and synaptic signaling networks.
Bluum Peptides supplies 6c Peptide as a research-grade compound supported by quality documentation and analytical testing. It is supplied exclusively for laboratory research use and is not intended for human or veterinary application.
6c Peptide Research Applications (Observations From Studies)
6c Peptide is studied across experimental models investigating CNTF-derived neurotrophic signaling, BDNF regulation, and neurogenesis. The research applications described below are based on biochemical studies, cellular models, and laboratory investigations. They should not be interpreted as evidence of therapeutic effects, clinical outcomes, or human or veterinary applications.
Neurotrophic Signaling Research
One of the primary research applications of 6c Peptide is the investigation of CNTF-mimetic activity at the minimal sequence level. Researchers study how the DGGL motif contributes to LIF/STAT3 pathway modulation and downstream neurotrophic signaling observed in parent-peptide research.
BDNF-Associated Expression Research
6c Peptide is used in research exploring transcriptional and translational changes in BDNF associated with CNTF-derived peptide exposure. Experimental models examine gene expression changes and downstream signaling intermediates linked to neuronal survival and plasticity pathways.
Neuronal Progenitor and Neurogenesis Research
Researchers investigate 6c Peptide in models of hippocampal and dentate gyrus neurogenesis, examining how the unmodified core sequence relates to neural progenitor proliferation and differentiation reported for related CNTF-derived compounds.
Structure-Activity Relationship Research
Because 6c Peptide is chemically distinct from P021, lacking the adamantane-based residue added to the parent sequence, it is used as a comparative reference in structure-activity relationship (SAR) studies. These studies help scientists evaluate how terminal modification affects blood-brain-barrier permeability, proteolytic stability, and receptor engagement relative to the unmodified tetrapeptide.
Synaptic Plasticity Research
6c Peptide is studied as a research tool for examining synaptic protein expression and plasticity markers in experimental models, contributing to a broader understanding of how CNTF-derived sequences influence neuronal connectivity.
Emerging Research Areas
CNTF-derived peptide research continues to be investigated in areas such as neurodegeneration, cognitive aging, and tauopathy biology due to associations between BDNF signaling and tau phosphorylation pathways reported for related compounds in this peptide family.
Current studies focus on understanding molecular mechanisms and pathway interactions rather than demonstrating medical applications or therapeutic effects.
Bluum Peptides supplies 6c Peptide exclusively as a research material for qualified laboratory use. No statements on this page should be interpreted as medical, therapeutic, diagnostic, human, or veterinary claims.
6c Peptide (Unmodified P21) vs SNAP-8 vs Selank: Neurotrophic Research Peptide Comparison
|
Characteristic |
6c Peptide (Unmodified P21) |
||
|
Research Classification |
Minimal unmodified CNTF-derived tetrapeptide |
Synthetic octapeptide fragment |
Synthetic heptapeptide derived from tuftsin |
|
Primary Receptor Targets |
Ac-DGGL-NH₂ |
SNAP-25 functional region within the SNARE complex |
Indirect modulation of GABA and monoamine systems; cytokine and immune signaling markers in models |
|
Mechanistic Profile |
401.42 g/mol (calculated) |
Peptide fragment used in protein-interaction studies |
Multi-pathway signaling modulation |
|
Primary Research Focus |
Minimal active-sequence signaling, SAR reference |
SNARE-complex interaction and vesicle fusion pathway studies |
GABAergic modulation, monoamine signaling, immune–neural cross-talk |
|
Experimental Scope |
Proposed LIF/STAT3 modulation via core DGGL motif |
Vesicle fusion models, protein-interaction studies, domain mapping; primarily in vitro and non-clinical systems |
Stress-response signalling models, neurochemical pathway studies, and brain-immune interaction research; neural + immune integrated signaling; probe for cross-system neurochemical and immune signaling |
|
Structural Design |
Compact, non-adamantylated tetrapeptide |
Domain-specific research probe examining a defined SNAP-25 sequence region |
Engineered tuftsin analog with extended sequence for stability and broader signaling reach; more stable than tuftsin due to sequence extension |
|
Current Research Status |
Cellular and rodent models, comparative SAR studies |
Research-use-only peptide |
Research-use peptide |
Research Note: The comparison above is intended to illustrate differences in molecular classification, biochemical roles, and experimental research applications within this peptide family. These compounds are discussed only in the context of laboratory investigation. The information should not be interpreted as evidence of clinical performance, therapeutic value, safety, or suitability for human or veterinary use.
Bluum Peptides supplies 6c Peptide (Unmodified P21) exclusively as a research material intended for qualified laboratory applications.
6c Peptide Laboratory Handling & Storage
6c Peptide is supplied as a lyophilized tetrapeptide research compound and should be handled using established laboratory practices appropriate for peptide research materials.
Laboratory handling procedures may vary depending on research protocols, institutional requirements, and study objectives. Bluum Peptides recommends following applicable laboratory standard operating procedures (SOPs) and safety guidelines when working with this product.
For general laboratory handling, researchers should consider the following best practices:
- Store unopened vials under recommended storage conditions and protect the material from light, moisture, and unnecessary environmental exposure.
- Handle the compound using appropriate personal protective equipment (PPE), including laboratory gloves, eye protection, and protective clothing where required.
- Use controlled laboratory environments to help minimize contamination and maintain sample integrity.
- Maintain batch records, Certificates of Analysis (COAs), and supporting documentation for traceability and research records.
- Dispose of unused material and laboratory waste according to institutional procedures and applicable regulations.
Because laboratory procedures vary between research environments, Bluum Peptides does not provide protocol-specific preparation or experimental instructions. 6c Peptide is supplied exclusively for laboratory research use and is not intended for human or veterinary application.
Certificate of Analysis (COA) & Quality Assurance
At Bluum Peptides, quality assurance is a key part of supplying research-grade compounds for laboratory applications. Each production lot of 6c Peptide undergoes analytical evaluation, with batch-specific Certificates of Analysis (COAs) available to support research documentation, quality control, and experimental consistency.
Each COA typically includes:
- Identity verification using analytical techniques such as mass spectrometry to confirm the molecular characteristics of 6c Peptide.
- Purity analysis performed using methods such as high-performance liquid chromatography (HPLC) to assess compound purity and identify potential impurities.
- Batch documentation, including lot number, testing information, analytical methods, and quality assessment results.
- Traceability information to support laboratory recordkeeping and reproducibility across research workflows.
Bluum Peptides works with independent analytical laboratories, including providers such as Janoshik, BioRegen, and Freedom Diagnostics, to support third-party verification of research material quality. Independent testing provides additional transparency and confidence in product identity, consistency, and sourcing.
Batch-specific COAs are available for review and can be retained as part of laboratory documentation, internal quality procedures, and research recordkeeping.
6c Peptide is supplied exclusively for laboratory research use and is not intended for human or veterinary application.
Frequently Asked Questions
What is 6c Peptide (Unmodified P21)?
6c Peptide (Unmodified P21) is a synthetic CNTF-derived tetrapeptide (Ac-DGGL-NH₂) studied in laboratory research as the minimal active sequence underlying the neurotrophic peptide P021. It is supplied exclusively for laboratory research use and is not intended for human or veterinary applications.
How is 6c Peptide different from P021?
6c Peptide corresponds to the unmodified Ac-DGGL-NH₂ sequence, while P021 adds an adamantylated glycine residue to the same core sequence to improve blood-brain-barrier permeability and stability. Researchers use 6c Peptide as a comparative reference to study how this terminal modification changes peptide behavior.
What is 6c Peptide studied for in research?
6c Peptide is studied in connection with CNTF-derived neurotrophic signaling, BDNF-associated gene expression, neuronal progenitor activity, and synaptic plasticity in cellular and rodent research models.
How does 6c Peptide work in laboratory research?
In research settings, 6c Peptide is investigated for its proposed role in partially modulating LIF/STAT3 signaling, a mechanism associated with increased BDNF transcription in related CNTF-derived peptide research.
How is the quality of Bluum Peptides 6c Peptide verified?
Bluum Peptides supports research-grade quality through analytical testing, batch documentation, and Certificates of Analysis (COAs). Quality verification may include methods such as HPLC and mass spectrometry, with independent testing from providers including Janoshik, BioRegen, and Freedom Diagnostics.
How should unopened 6c Peptide be stored?
Unopened 6c Peptide should be stored under recommended laboratory conditions and protected from light and moisture. Researchers should follow their approved storage procedures and institutional guidelines, referring to batch-specific handling documentation.
Is 6c Peptide intended for human use?
No. 6c Peptide is supplied strictly for laboratory research use only. It is not approved for human consumption, veterinary use, diagnosis, treatment, or medical applications.
Why do researchers choose Bluum Peptides for 6c Peptide?
Bluum Peptides provides research-grade compounds supported by analytical documentation, Certificates of Analysis, and third-party verification where applicable. Researchers benefit from transparent quality standards, batch traceability, and reliable sourcing for laboratory applications.
Scientific References
- Blanchard, J., Chohan, M. O., Li, B., et al. (2010). Neurotrophic peptides incorporating adamantane improve learning and memory, promote neurogenesis and synaptic plasticity in mice. Neurobiology of Aging / ScienceDirect.
https://www.sciencedirect.com/science/article/pii/S001457931000520X - Chohan, M. O., Li, B., Blanchard, J., et al. (2011). Enhancement of dentate gyrus neurogenesis, memory, and blood-brain barrier permeability by CNTF-derived peptidergic compound P021. (Referenced in Neurotrophic Peptides patent filings, US Patent 9,327,011).
https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/9327011 - Baazaoui, N., & Iqbal, K. (2017). Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic peptide P021 in a mouse model of Alzheimer's disease. Neurobiology of Aging / ResearchGate.
https://www.researchgate.net/publication/45091123_Neurotrophic_peptides_incorporating_adamantane_improve_learning_and_memory_promote_neurogenesis_and_synaptic_plasticity_in_mice - Kazim, S. F., Blanchard, J., Bianchi, R., & Iqbal, K. (2019). Early neurotrophic peptide P021 treatment prevents cognitive impairment in a mouse model of Alzheimer's disease. ScienceDirect.
https://www.sciencedirect.com/science/article/pii/S001457931000520X - Zamberletti, E., et al. (2024). Effects of a ciliary neurotrophic factor (CNTF) small-molecule peptide mimetic in an in vitro and in vivo model of CDKL5 deficiency disorder. PMC.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11590213/